Genome-wide profiling of genetic synthetic lethality identifies CDK12 as a novel determinant of PARP1/2 inhibitor sensitivity.

Abstract:

:Small-molecule inhibitors of PARP1/2, such as olaparib, have been proposed to serve as a synthetic lethal therapy for cancers that harbor BRCA1 or BRCA2 mutations. Indeed, in clinical trials, PARP1/2 inhibitors elicit sustained antitumor responses in patients with germline BRCA gene mutations. In hypothesizing that additional genetic determinants might direct use of these drugs, we conducted a genome-wide synthetic lethal screen for candidate olaparib sensitivity genes. In support of this hypothesis, the set of identified genes included known determinants of olaparib sensitivity, such as BRCA1, RAD51, and Fanconi's anemia susceptibility genes. In addition, the set included genes implicated in established networks of DNA repair, DNA cohesion, and chromatin remodeling, none of which were known previously to confer sensitivity to PARP1/2 inhibition. Notably, integration of the list of candidate sensitivity genes with data from tumor DNA sequencing studies identified CDK12 deficiency as a clinically relevant biomarker of PARP1/2 inhibitor sensitivity. In models of high-grade serous ovarian cancer (HGS-OVCa), CDK12 attenuation was sufficient to confer sensitivity to PARP1/2 inhibition, suppression of DNA repair via homologous recombination, and reduced expression of BRCA1. As one of only nine genes known to be significantly mutated in HGS-OVCa, CDK12 has properties that should confirm interest in its use as a biomarker, particularly in ongoing clinical trials of PARP1/2 inhibitors and other agents that trigger replication fork arrest.

journal_name

Cancer Res

journal_title

Cancer research

authors

Bajrami I,Frankum JR,Konde A,Miller RE,Rehman FL,Brough R,Campbell J,Sims D,Rafiq R,Hooper S,Chen L,Kozarewa I,Assiotis I,Fenwick K,Natrajan R,Lord CJ,Ashworth A

doi

10.1158/0008-5472.CAN-13-2541

subject

Has Abstract

pub_date

2014-01-01 00:00:00

pages

287-97

issue

1

eissn

0008-5472

issn

1538-7445

pii

0008-5472.CAN-13-2541

journal_volume

74

pub_type

杂志文章
  • The androgen receptor and genetic susceptibility to ovarian cancer: results from a case series.

    abstract::Our objectives were to test whether polymorphic variation in the (CAG)n repeat of the androgen receptor (AR) gene affects penetrance of germ-line BRCA mutations for ovarian cancer or age of diagnosis for ovarian cancer. Using a case-series study design, 179 consecutive Ashkenazi Jewish ovarian cancer patients were gen...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Levine DA,Boyd J

    更新日期:2001-02-01 00:00:00

  • Combination chemotherapy in vitro exploiting glutamine metabolism of human glioma and medulloblastoma.

    abstract::The human glioma-derived cell line D-54 MG and the human medulloblastoma-derived cell line TE-671 have been shown to be sensitive in culture to the pharmacological interference with glutamine metabolism by acivicin, 6-diazo-5-oxo-L-norleucine, and methionine sulfoximine. Using as a guide the multiple contributions of ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Dranoff G,Elion GB,Friedman HS,Bigner DD

    更新日期:1985-09-01 00:00:00

  • Tumor-Derived TGFβ Alters the Ability of Plasmacytoid Dendritic Cells to Respond to Innate Immune Signaling.

    abstract::A growing number of observations has suggested that plasmacytoid dendritic cells (pDC) play a critical role in tumor biology. In patients, infiltration of tumors by pDCs generally correlates with a poor prognosis, suggesting that pDCs may play an important role in the host-tumor relationship. Here, we analyze the infl...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-17-2719

    authors: Terra M,Oberkampf M,Fayolle C,Rosenbaum P,Guillerey C,Dadaglio G,Leclerc C

    更新日期:2018-06-01 00:00:00

  • Biological considerations for radioimmunotherapy.

    abstract::We have examined three methods that may be useful for improving the therapeutic efficacy of antibody-targeted radionuclides. The principal limitation of radioimmunotherapy is myelotoxicity and thrombocytopenia. These are due mainly to the length of time the radioantibody remains in the blood. The clearance time of a r...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Sharkey RM,Blumenthal RD,Hansen HJ,Goldenberg DM

    更新日期:1990-02-01 00:00:00

  • Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: biodistribution and imaging studies.

    abstract::We have examined the distribution of radiolabeled liposomes in tumor-bearing mice after i.v. injection. Two mouse tumors (B16 melanoma, J6456 lymphoma) and a human tumor (LS174T colon carcinoma) inoculated i.m., s.c., or in the hind footpad were used in these studies. When various liposome compositions with a mean ves...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gabizon A,Price DC,Huberty J,Bresalier RS,Papahadjopoulos D

    更新日期:1990-10-01 00:00:00

  • Inhibition of nuclear factor-kappaB activity by temozolomide involves O6-methylguanine induced inhibition of p65 DNA binding.

    abstract::The alkylating agent temozolomide, commonly used in the treatment of malignant glioma, causes cellular cytotoxicity by forming O(6)-methylguanine adducts. In this report, we investigated whether temozolomide alters the activity of the transcription factor nuclear factor-kappaB (NF-kappaB). Temozolomide inhibits basal ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-4496

    authors: Yamini B,Yu X,Dolan ME,Wu MH,Darga TE,Kufe DW,Weichselbaum RR

    更新日期:2007-07-15 00:00:00

  • Acidity generated by the tumor microenvironment drives local invasion.

    abstract::The pH of solid tumors is acidic due to increased fermentative metabolism and poor perfusion. It has been hypothesized that acid pH promotes local invasive growth and metastasis. The hypothesis that acid mediates invasion proposes that H(+) diffuses from the proximal tumor microenvironment into adjacent normal tissues...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-12-2796

    authors: Estrella V,Chen T,Lloyd M,Wojtkowiak J,Cornnell HH,Ibrahim-Hashim A,Bailey K,Balagurunathan Y,Rothberg JM,Sloane BF,Johnson J,Gatenby RA,Gillies RJ

    更新日期:2013-03-01 00:00:00

  • Radiosensitive barrier to T-cell-mediated adoptive immunotherapy of established tumors.

    abstract::This study shows that it is not possible to cause regression of the immunogenic SA-1 sarcoma by adoptive immunotherapy with tumor-sensitized T-cells, unless the tumor-bearing recipient is exposed to a sublethal dose of gamma-irradiation to remove a barrier that prevents adoptive immunity from being expressed. This bar...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Awwad M,North RJ

    更新日期:1990-04-15 00:00:00

  • Therapeutic Targeting of Metadherin Suppresses Colorectal and Lung Cancer Progression and Metastasis.

    abstract::Colorectal and lung cancers account for one-third of all cancer-related deaths worldwide. Previous studies suggested that Metadherin (MTDH) is involved in the development of colorectal and lung cancers. However, how MTDH regulates the pathogenesis of these cancers remains largely unknown. Using genetically modified mo...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-20-1876

    authors: Shen M,Xie S,Rowicki M,Michel S,Wei Y,Hang X,Wan L,Lu X,Yuan M,Jin JF,Jaschinski F,Zhou T,Klar R,Kang Y

    更新日期:2020-11-25 00:00:00

  • Metastatic growth progression caused by PSGL-1-mediated recruitment of monocytes to metastatic sites.

    abstract::Tumor cell-derived selectin ligands mediate contact to the endothelium, platelets, and leukocytes through binding to selectins that facilitates metastasis. Here, we describe the mechanism of how endogenous (non-tumor derived) selectin ligands contribute to metastasis using α(1,3)fucosyltransferase 7 (Fuc-TVII(-/-))-de...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-0946

    authors: Hoos A,Protsyuk D,Borsig L

    更新日期:2014-02-01 00:00:00

  • Treatment of the mouse Lewis tumor by the association of radiotherapy and immunotherapy with Bacillus Calmette-Guérin.

    abstract::Three groups of 6 to 8-week-old male mice with transplanted C57BL/6 X DBA/2F1 tumor were irradiated by a single dose of 60Co localized on the tumor in association with i.p. injections of lyophilized Bacillus Calmette-Guérin. When the animals were sacrificed, tumor parameters (weight, surface area, and volume) were det...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Dubois JB,Serrou B

    更新日期:1976-05-01 00:00:00

  • Eukaryotic expression cloning with an antimetastatic monoclonal antibody identifies a tetraspanin (PETA-3/CD151) as an effector of human tumor cell migration and metastasis.

    abstract::A monoclonal antibody (mAb), 50-6, generated by subtractive immunization, was found to specifically inhibit in vivo metastasis of a human epidermoid carcinoma cell line, HEp-3. The cDNA of the cognate antigen of mAb 50-6 was isolated by a modified eukaryotic expression cloning protocol from a HEp-3 library. Sequence a...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Testa JE,Brooks PC,Lin JM,Quigley JP

    更新日期:1999-08-01 00:00:00

  • Thanatop: a novel 5-nitrofuran that is a highly active, cell-permeable inhibitor of topoisomerase II.

    abstract::A series of nitrofuran-based compounds were identified as inhibitors of estrogen signaling in a cell-based, high-throughput screen of a diverse library of small molecules. These highly related compounds were subsequently found to inhibit topoisomerase II in vitro at concentrations similar to that required for the inhi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-0393

    authors: Polycarpou-Schwarz M,Müller K,Denger S,Riddell A,Lewis J,Gannon F,Reid G

    更新日期:2007-05-01 00:00:00

  • An unexpected biotransformation pathway for tetrachloro-(d,l-trans)-1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) in the L1210 cell line.

    abstract::Tetrachloro(d,l-trans)-1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) has been considered a prodrug which would be converted rapidly to dichloro(d,l-trans)-1,2-diaminocyclohexaneplatinum(II) [PtCl2(dach)] under physiological conditions. However, the biotransformations of tetraplatin have not been studied in detail. ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Chaney SG,Gibbons GR,Wyrick SD,Podhasky P

    更新日期:1991-02-01 00:00:00

  • DNA polymerase beta gene mutation in human prostate cancer.

    abstract::DNA polymerase beta is a nuclear protein essential to DNA repair in mammalian cells. A high frequency of mutations in this gene has been reported in colorectal cancers. To clarify the tumorigenesis steps of human prostate cancers in the molecular basis, we examined the entire coding region of the human DNA polymerase ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Dobashi Y,Shuin T,Tsuruga H,Uemura H,Torigoe S,Kubota Y

    更新日期:1994-06-01 00:00:00

  • Using a xenograft model of human breast cancer metastasis to find genes associated with clinically aggressive disease.

    abstract::Metastasis is the primary cause of death from breast cancer. A xenograft model was used to identify genes potentially involved with metastasis, comparing expression in the poorly metastatic GI101A human breast cancer cell line and a highly metastatic variant, GILM2. cDNA microarray analyses of these isogenic variants ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-0108

    authors: Kluger HM,Chelouche Lev D,Kluger Y,McCarthy MM,Kiriakova G,Camp RL,Rimm DL,Price JE

    更新日期:2005-07-01 00:00:00

  • Different concanavalin A binding patterns of malignant and nonmalignant mouse mammary epithelia in monolayer culture.

    abstract::Concanavalin A (Con A) binding of fixed malignant and nonmalignant C3H/He mouse mammary epithelia in monolayer cultures was examined with markers and labels of various sizes. In Con A-mediated hemadsorption, high epithelial cell densities resulted in the adsorbance of more guinea pig red blood cells per culture dish b...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Mitani H,Murakami A,Tanaka H

    更新日期:1984-02-01 00:00:00

  • Frequency of the CHEK2 1100delC mutation among women with breast cancer: an international study.

    abstract::A founder allele in the CHEK2 gene (1100delC) has been associated with an elevated risk of breast cancer. This allele is responsible for the majority of CHEK2-associated breast cancers in women from northern European countries; however, within Europe, it seems to be rare in countries that are close to the Mediterranea...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-5187

    authors: Zhang S,Phelan CM,Zhang P,Rousseau F,Ghadirian P,Robidoux A,Foulkes W,Hamel N,McCready D,Trudeau M,Lynch H,Horsman D,De Matsuda ML,Aziz Z,Gomes M,Costa MM,Liede A,Poll A,Sun P,Narod SA

    更新日期:2008-04-01 00:00:00

  • Induction of cell death by basic fibroblast growth factor in Ewing's sarcoma.

    abstract::Ewing's sarcoma is thought to arise after developmental arrest of primitive neural cells during embryogenesis. Because basic fibroblast growth factor (bFGF) has a critical role in the regulation of cell survival, proliferation, and differentiation during embryogenesis, we have tested the hypothesis that bFGF and FGF r...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Sturla LM,Westwood G,Selby PJ,Lewis IJ,Burchill SA

    更新日期:2000-11-01 00:00:00

  • Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene.

    abstract::Mitogen-activated protein kinase (MAPK) kinase 4 (MKK4) is a component of a stress and cytokine-induced signal transduction pathway involving MAPK proteins. The MKK4 protein has been implicated in activation of JNK1 and p38 MAPK on phosphorylation by conserved kinase pathways. A recent report on the deletion and mutat...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Su GH,Hilgers W,Shekher MC,Tang DJ,Yeo CJ,Hruban RH,Kern SE

    更新日期:1998-06-01 00:00:00

  • Netrin-1 and Its Receptor DCC Are Causally Implicated in Melanoma Progression.

    abstract::Deleted in colorectal cancer (DCC), the receptor for the multifunctional cue netrin-1, acts as a tumor suppressor in intestinal cancer and lung metastasis by triggering cancer cell death when netrin-1 is lowly expressed. Recent genomic data highlighted that DCC is the third most frequently mutated gene in melanoma; we...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-18-1590

    authors: Boussouar A,Tortereau A,Manceau A,Paradisi A,Gadot N,Vial J,Neves D,Larue L,Battistella M,Leboeuf C,Lebbé C,Janin A,Mehlen P

    更新日期:2020-02-15 00:00:00

  • Frequency of urination and its effects on metabolism, pharmacokinetics, blood hemoglobin adduct formation, and liver and urinary bladder DNA adduct levels in beagle dogs given the carcinogen 4-aminobiphenyl.

    abstract::The human urinary bladder carcinogen, 4-aminobiphenyl (ABP), is known to undergo hepatic metabolism to an N-hydroxy arylamine and its corresponding N-glucuronide. It has been proposed that these metabolites are both transported through the blood via renal filtration to the urinary bladder lumen where acidic pH can fac...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kadlubar FF,Dooley KL,Teitel CH,Roberts DW,Benson RW,Butler MA,Bailey JR,Young JF,Skipper PW,Tannenbaum SR

    更新日期:1991-08-15 00:00:00

  • Inactivation of Smad4 in gastric carcinomas.

    abstract::Allelic loss of chromosome 18q has been noted in intestinal type gastric adenocarcinomas. Smad4 is a gene located at 18q that was recently cloned in humans and found to be significantly altered in pancreatic cancers. We sought to determine whether Smad4 genetic alterations played a significant role in gastric tumorige...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Powell SM,Harper JC,Hamilton SR,Robinson CR,Cummings OW

    更新日期:1997-10-01 00:00:00

  • Nonrandom nature of in vivo methylation of dimethylnitrosamine and the subsequent removal of methylated products from rat liver chromatin DNA.

    abstract::This investigation was designed to study whether methylation of liver chromatin DNA by dimethylnitrosamine (DMN) and the subsequent in vivo removal of DNA-bound methylated products are random. Liver chromatin DNA was fractionated into nuclease-digestible and nondigestible material 4 hr following the administration of ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ramanathan R,Rajalakshmi S,Sarma DS,Farber E

    更新日期:1976-06-01 00:00:00

  • Plasminogen activators and tumor development in the human colon: activity levels in normal mucosa, adenomatous polyps, and adenocarcinomas.

    abstract::Malignant changes are often accompanied by alterations in activity and composition of the plasminogen activators (PA). To study the relationship between PA expression and the development of colorectal cancer, we determined urokinase-type plasminogen activator (u-PA) and tissue-type plasminogen activator (t-PA) activit...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: de Bruin PA,Griffioen G,Verspaget HW,Verheijen JH,Lamers CB

    更新日期:1987-09-01 00:00:00

  • Purine nucleotide levels in host tissues of Ehrlich ascites tumor-bearing mice in different growth phases of the tumor.

    abstract::The pool sizes of purine nucleotides, nucleosides, and nucleobases were measured in the host tissues liver, skeletal muscle, and blood of Ehrlich ascites tumor-bearing mice during the different periods of tumor growth. There were large differences of tissue concentrations of these metabolites between control animals, ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Siems WG,Grune T,Schmidt H,Tikhonov YV,Pimenov AM

    更新日期:1993-11-01 00:00:00

  • Involvement of Ras activation in human breast cancer cell signaling, invasion, and anoikis.

    abstract::Although mutated forms of ras are not associated with the majority of breast cancers (<5%), there is considerable experimental evidence that hyperactive Ras can promote breast cancer growth and development. Therefore, we determined whether Ras and Ras-responsive signaling pathways were activated persistently in nine w...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-0396

    authors: Eckert LB,Repasky GA,Ulkü AS,McFall A,Zhou H,Sartor CI,Der CJ

    更新日期:2004-07-01 00:00:00

  • Expression of endogenous murine leukemia virus in transplantable tumor cells and DNA methylation of the viral sequences.

    abstract::A cell line derived from early passage of a transplantable tumor in athymic mice that initially had been injected with human breast adenocarcinoma cells produced a substantial amount of RNA sequences related to the Kirsten murine leukemia virus. The cell line derived from later passage of transplantation of these tumo...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kuo MT,Sen S,Teeter L,Cailleau RM,Knesek JE,Bowen J

    更新日期:1984-08-01 00:00:00

  • Ultrasonically activated chemotherapeutic drug delivery in a rat model.

    abstract::Systemic delivery of anticancer agents is accompanied by many unwanted side effects that can be mitigated by encapsulation of antineoplastic agents. However, encapsulation necessitates a technique for controlled delivery to the cancerous tissue. We have developed a novel drug delivery system that releases drug from st...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Nelson JL,Roeder BL,Carmen JC,Roloff F,Pitt WG

    更新日期:2002-12-15 00:00:00

  • Detection of brain tumor cells in the peripheral blood by a telomerase promoter-based assay.

    abstract::Blood tests to detect circulating tumor cells (CTC) offer great potential to monitor disease status, gauge prognosis, and guide treatment decisions for patients with cancer. For patients with brain tumors, such as aggressive glioblastoma multiforme, CTC assays are needed that do not rely on expression of cancer cell s...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-0813

    authors: Macarthur KM,Kao GD,Chandrasekaran S,Alonso-Basanta M,Chapman C,Lustig RA,Wileyto EP,Hahn SM,Dorsey JF

    更新日期:2014-04-15 00:00:00